CY1116526T1 - Διαδικασια για καθαρισμο πρωτεϊνων - Google Patents

Διαδικασια για καθαρισμο πρωτεϊνων

Info

Publication number
CY1116526T1
CY1116526T1 CY20151100535T CY151100535T CY1116526T1 CY 1116526 T1 CY1116526 T1 CY 1116526T1 CY 20151100535 T CY20151100535 T CY 20151100535T CY 151100535 T CY151100535 T CY 151100535T CY 1116526 T1 CY1116526 T1 CY 1116526T1
Authority
CY
Cyprus
Prior art keywords
recombinant
recombinant protein
host cell
cleaning procedure
isomerase
Prior art date
Application number
CY20151100535T
Other languages
English (en)
Inventor
Gavin Barry Wild
Original Assignee
Ucb Biopharma Sprl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Biopharma Sprl filed Critical Ucb Biopharma Sprl
Publication of CY1116526T1 publication Critical patent/CY1116526T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'

Abstract

Η παρούσα εφεύρεση παρέχει μια μέθοδο για τον καθαρισμό μιας ανασυνδυαστικής πρωτεΐνης από ένα αρνητικό κατά gram βακτηριακό δείγμα κυττάρου ξενιστή ή ένα εκχύλισμα αυτού, όπου το εν λόγω κύτταρο ξενιστή εκφράζει μια ανασυνδυαστική πρωτεΐνη και μια ανασυνδυαστική ισομεράση δισουλφιδίου DsbC. Η εφεύρεση περιλαμβάνει: α. την προσαρμογή του pΗ του δείγματος κυττάρου ξενιστή ή ενός εκχυλίσματος αυτού σε ένα pΗ 5 ή λιγότερο προκειμένου να καθιζάσει την ανασυνδυαστική ισομεράση δισουλφιδίου και β. τον διαχωρισμό της καθιζημένης ανασυνδυαστικής ισομεράσης δισουλφιδίου DsbC από την ανασυνδυαστική πρωτεΐνη ώστε να παράσχει ένα δείγμα ανασυνδυαστικής πρωτεΐνης.
CY20151100535T 2010-07-27 2015-06-23 Διαδικασια για καθαρισμο πρωτεϊνων CY1116526T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1012599.5A GB201012599D0 (en) 2010-07-27 2010-07-27 Process for purifying proteins
EP11745810.9A EP2598516B8 (en) 2010-07-27 2011-07-27 Process for purifying proteins

Publications (1)

Publication Number Publication Date
CY1116526T1 true CY1116526T1 (el) 2017-03-15

Family

ID=42752868

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151100535T CY1116526T1 (el) 2010-07-27 2015-06-23 Διαδικασια για καθαρισμο πρωτεϊνων

Country Status (24)

Country Link
US (1) US9751930B2 (el)
EP (1) EP2598516B8 (el)
JP (1) JP5935222B2 (el)
KR (1) KR101944121B1 (el)
CN (1) CN103189385B (el)
AU (1) AU2011284548B2 (el)
BR (1) BR112013000177B1 (el)
CA (1) CA2804099C (el)
CY (1) CY1116526T1 (el)
DK (1) DK2598516T3 (el)
ES (1) ES2537877T3 (el)
GB (1) GB201012599D0 (el)
HR (1) HRP20150639T1 (el)
HU (1) HUE026049T2 (el)
IL (1) IL224044A (el)
ME (1) ME02162B (el)
MX (1) MX337184B (el)
PL (1) PL2598516T3 (el)
PT (1) PT2598516E (el)
RS (1) RS54085B1 (el)
SG (2) SG196862A1 (el)
SI (1) SI2598516T1 (el)
SM (1) SMT201500142B (el)
WO (1) WO2012013930A2 (el)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2993231T3 (pl) 2009-09-24 2019-01-31 Ucb Biopharma Sprl Szczep bakteryjny do ekspresji rekombinowanego białka mający degp pozbawione aktywności proteazowej przy zachowaniu aktywności białka opiekuńczego i nokauty genów tsp i ptr
GB201000590D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201000587D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201000591D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201001791D0 (en) 2010-02-03 2010-03-24 Ucb Pharma Sa Process for obtaining antibodies
PT2731973T (pt) 2011-07-13 2018-02-22 Ucb Biopharma Sprl Estirpe hospedeira bacteriana que expressa dsbc recombinante
GB201208367D0 (en) * 2012-05-14 2012-06-27 Ucb Pharma Sa Biological product
WO2013180648A1 (en) * 2012-05-31 2013-12-05 Agency For Science, Technology And Research Methods for use of mixed multifunctional surfaces for reducing aggregate content in protein preparations
EP2855504B1 (en) 2012-05-31 2018-10-24 Agency For Science, Technology And Research Chromatographic purification of immunoglobulin g preparations with particles having multimodal functionalities
AU2015371341B2 (en) 2014-12-22 2021-05-20 Ucb Biopharma Sprl Method of protein manufacture
CA2969889A1 (en) * 2014-12-22 2016-06-30 Ucb Biopharma Sprl Protein manufacture
SI3265557T1 (sl) * 2015-03-06 2020-02-28 F. Hoffmann-La Roche Ag Ultraprečiščena DsbA in DsbC ter postopki njune izdelave in uporabe
CN110272491B (zh) * 2018-03-13 2023-01-24 江苏恒瑞医药股份有限公司 一种抗pd-1抗体的纯化工艺
KR20220031670A (ko) * 2019-08-05 2022-03-11 와커 헤미 아게 발효 방법에서 재조합 단백질 방출용 박테리아 균주

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
GB8719042D0 (en) 1987-08-12 1987-09-16 Parker D Conjugate compounds
US5030570A (en) 1988-06-30 1991-07-09 The Eunice Kennedy Shriver Center For Mental Retardation DNA encoding and method of expressing human monoamine oxidase type A
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
GB8907617D0 (en) 1989-04-05 1989-05-17 Celltech Ltd Drug delivery system
GB8928874D0 (en) 1989-12-21 1990-02-28 Celltech Ltd Humanised antibodies
EP0542810A1 (en) 1990-08-02 1993-05-26 B.R. Centre Limited Methods for the production of proteins with a desired function
US5264365A (en) 1990-11-09 1993-11-23 Board Of Regents, The University Of Texas System Protease-deficient bacterial strains for production of proteolytically sensitive polypeptides
US5508192A (en) 1990-11-09 1996-04-16 Board Of Regents, The University Of Texas System Bacterial host strains for producing proteolytically sensitive polypeptides
GB9112536D0 (en) 1991-06-11 1991-07-31 Celltech Ltd Chemical compounds
GB9113120D0 (en) 1991-06-18 1991-08-07 Kodak Ltd Photographic processing apparatus
GB9120467D0 (en) 1991-09-26 1991-11-06 Celltech Ltd Anti-hmfg antibodies and process for their production
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
GB9215540D0 (en) 1992-07-22 1992-09-02 Celltech Ltd Protein expression system
US6027888A (en) * 1996-04-05 2000-02-22 Board Of Regents, The University Of Texas System Methods for producing soluble, biologically-active disulfide-bond containing eukaryotic proteins in bacterial cells
GB9625640D0 (en) 1996-12-10 1997-01-29 Celltech Therapeutics Ltd Biological products
US6083715A (en) * 1997-06-09 2000-07-04 Board Of Regents, The University Of Texas System Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells
EP1190258B1 (en) 1999-06-29 2006-10-25 Siga Technologies, Inc. Assay for degp protease inhibitors
GB0006398D0 (en) 2000-03-16 2000-05-03 Novartis Ag Organic compounds
GB0013810D0 (en) 2000-06-06 2000-07-26 Celltech Chiroscience Ltd Biological products
AU8867501A (en) 2000-09-01 2002-03-13 Biogen Inc Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
AU2001287040A1 (en) 2000-09-01 2002-03-13 Biogen, Inc. Methods of designing and producing novel compounds having improved binding affinity for cd154 or other trimeric proteins
US7041479B2 (en) * 2000-09-06 2006-05-09 The Board Of Trustess Of The Leland Stanford Junior University Enhanced in vitro synthesis of active proteins containing disulfide bonds
ES2312494T3 (es) 2000-12-14 2009-03-01 Genentech, Inc. Produccion de anticuerpos completos en celulas procariotas.
ATE318890T1 (de) 2000-12-14 2006-03-15 Genentech Inc Bakterielle wirtstämme
WO2004003019A2 (en) 2002-06-28 2004-01-08 Domantis Limited Immunoglobin single variant antigen-binding domains and dual-specific constructs
TWI327597B (en) 2001-08-01 2010-07-21 Centocor Inc Anti-tnf antibodies, compositions, methods and uses
CA2454731C (en) 2001-08-27 2010-11-02 Genentech, Inc. A system for antibody expression and assembly
GB0124317D0 (en) 2001-10-10 2001-11-28 Celltech R&D Ltd Biological products
EP2022799A2 (en) 2001-11-16 2009-02-11 Biogen Idec Inc. Polycistronic expression of antibodies
GB0129105D0 (en) 2001-12-05 2002-01-23 Celltech R&D Ltd Expression control using variable intergenic sequences
WO2004042017A2 (en) * 2002-10-31 2004-05-21 Genentech, Inc. Methods and compositions for increasing antibody production
EP1570267B1 (en) 2002-12-03 2011-10-12 UCB Pharma, S.A. Assay for identifying antibody producing cells
ZA200504990B (en) 2003-01-09 2006-08-30 Genentech Inc Purification of polypeptides
GB0303337D0 (en) 2003-02-13 2003-03-19 Celltech R&D Ltd Biological products
AU2004253868B2 (en) 2003-06-13 2011-06-16 Biogen Ma Inc. Aglycosyl anti-CD154 (CD40 ligand) antibodies and uses thereof
PL1639011T3 (pl) 2003-06-30 2009-05-29 Domantis Ltd Pegilowane przeciwciała jednodomenowe (dAb)
GB0315450D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
GB0315457D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
AU2004261198A1 (en) 2003-07-26 2005-02-10 Biogen Idec Ma Inc. Altered antibodies having improved antigen-binding affinity
WO2006033702A2 (en) 2004-07-26 2006-03-30 Biogen Idec Ma Inc. Anti-cd154 antibodies
WO2006028936A2 (en) 2004-09-02 2006-03-16 Genentech, Inc. Heteromultimeric molecules
US7563443B2 (en) 2004-09-17 2009-07-21 Domantis Limited Monovalent anti-CD40L antibody polypeptides and compositions thereof
GB0425534D0 (en) 2004-11-19 2004-12-22 Celltech R&D Ltd Process for obtaining antibodies
SI2125894T1 (sl) 2007-03-22 2019-05-31 Biogen Ma Inc. Vezavne beljakovine, vključno s protitelesi, derivati protiteles in fragmenti protiteles, ki specifično vežejo CD154, ter njihove uporabe
US7662587B1 (en) 2009-03-05 2010-02-16 E. I. Du Pont De Nemours And Company Gene knockout mutations that increase peptide production
PL2993231T3 (pl) 2009-09-24 2019-01-31 Ucb Biopharma Sprl Szczep bakteryjny do ekspresji rekombinowanego białka mający degp pozbawione aktywności proteazowej przy zachowaniu aktywności białka opiekuńczego i nokauty genów tsp i ptr
US8470552B2 (en) 2009-10-12 2013-06-25 Keck Graduate Institute Strategy to reduce lactic acid production and control PH in animal cell culture
EP2496601B1 (en) 2009-11-05 2017-06-07 F. Hoffmann-La Roche AG Methods and composition for secretion of heterologous polypeptides
GB201000588D0 (en) * 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201000591D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201000587D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201000590D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201001791D0 (en) 2010-02-03 2010-03-24 Ucb Pharma Sa Process for obtaining antibodies
PT2731973T (pt) 2011-07-13 2018-02-22 Ucb Biopharma Sprl Estirpe hospedeira bacteriana que expressa dsbc recombinante
EP2546267A1 (en) 2011-07-13 2013-01-16 UCB Pharma S.A. Bacterial host strain expressing recombinant DsbC
GB201208367D0 (en) 2012-05-14 2012-06-27 Ucb Pharma Sa Biological product

Also Published As

Publication number Publication date
SMT201500142B (it) 2015-09-07
ES2537877T3 (es) 2015-06-15
SG196862A1 (en) 2014-02-13
CA2804099A1 (en) 2012-02-02
CN103189385B (zh) 2016-06-15
BR112013000177B1 (pt) 2021-11-09
SI2598516T1 (sl) 2015-07-31
GB201012599D0 (en) 2010-09-08
EP2598516B1 (en) 2015-03-25
ME02162B (me) 2015-10-20
MX2013000899A (es) 2013-05-22
KR20130103713A (ko) 2013-09-24
JP5935222B2 (ja) 2016-06-15
AU2011284548A1 (en) 2013-02-07
WO2012013930A3 (en) 2012-05-03
IL224044A (en) 2016-09-29
BR112013000177A2 (pt) 2020-09-24
EP2598516A2 (en) 2013-06-05
PT2598516E (pt) 2015-07-22
KR101944121B1 (ko) 2019-01-30
PL2598516T3 (pl) 2015-10-30
EP2598516B8 (en) 2015-07-15
SG186974A1 (en) 2013-02-28
HUE026049T2 (en) 2016-05-30
RS54085B1 (en) 2015-10-30
HRP20150639T1 (hr) 2015-07-17
DK2598516T3 (da) 2015-06-15
US20130178607A1 (en) 2013-07-11
AU2011284548B2 (en) 2015-11-26
CN103189385A (zh) 2013-07-03
CA2804099C (en) 2018-07-10
JP2013535463A (ja) 2013-09-12
WO2012013930A2 (en) 2012-02-02
MX337184B (es) 2016-02-16
US9751930B2 (en) 2017-09-05

Similar Documents

Publication Publication Date Title
CY1116526T1 (el) Διαδικασια για καθαρισμο πρωτεϊνων
CY1123952T1 (el) Απομονωση και καθαρισμος αντισωματων αντι-il-13 με την χρηση χρωματογραφιας χημικης συγγενειας πρωτεινης α
PH12017501114A1 (en) Anti-c5 antibodies and methods of use
CY1123299T1 (el) Ανοσοενισχυτικη μηνιγκιτιδοκοκκικη πρωτεϊνη προσδεσης παραγοντα η
CY1120951T1 (el) Ανθρωπινα αντισωματα enanti-tau
EA201391282A1 (ru) Клеточные линии с низким содержанием фукозы и их применение
CR20120371A (es) Antagonistas de pcsk9
EA201591017A1 (ru) Композиции и способы для лечения рака с применением бактерий
EA200801679A1 (ru) Композиции и способы применения антител к dickkopf-1 и/или -4
NZ724296A (en) Antibodies for treatment of cancer expressing claudin 6
WO2011136624A3 (ko) 자기장 인가부를 구비한 생물학적 시료 자동정제장치, 생물학적 시료로부터 타겟물질을 추출하는 방법, 그리고 단백질 발현 및 정제 방법
NZ578844A (en) Human cytomegalovirus neutralising antibodies and use thereof
EA201490825A8 (ru) Tdp-43-специфически связывающие молекулы
GB201003701D0 (en) System for the expression of a protein
EA201190041A1 (ru) Человеческие аутоантитела против альфа-синуклеина
AR083747A1 (es) Anticuerpos anti-il-23
ECSP13012673A (es) Métodos y composiciones para inmunoterapia para enfermedad neural
CL2012000822A1 (es) Acido nucleico aislado del virus de peces prv; polipeptido aislado; anticuerpo que se une a dicho polipeptido; metodo para determinar la presencia o ausencia de prv en una muestra biologica; arn interferente; metodo para reducir nivel de proteina viral.
DK2089516T3 (da) Fremgangsmåder til at forbedre indføringen af DNA i bakterielle celler
EA201892774A1 (ru) Антитела
EA201690503A1 (ru) Антитела
EP2516624A4 (en) CELL LINE 3M
SG10201807572PA (en) Robust antibody purification
WO2008085962A3 (en) Cell culture methods for producing recombinant proteins in the presence of reduced levels of one or more contaminants
EP3103810A3 (en) Modified variable domain molecules and methods for producing and using them